Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03719144 · ClinicalTrials.gov registry record
Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation
A clinical trial of Atrial Fibrillation, sponsored by Duke University.
- Completed
- Registry status
- 581
- Enrollment target
- 1
- Study location
NCT03719144 is a study of Atrial Fibrillation that has completed, run by Duke University. The registered enrollment target is 581 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03719144, a study of Atrial Fibrillation, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 581 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will survey atrial fibrillation patients to better understand patient perspective of DOAC treatment, and providers to assess knowledge, practice patterns, and beliefs surrounding anticoagulation for AF.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 581 participants |
| Start Date | 2019-04-08 |
| Est. Completion | 2020-03-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03719144
The ClinicalTrials.gov registry entry for NCT03719144 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 581 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (81% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT03719144 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03719144 about?
NCT03719144 is a clinical study titled "Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation". This study will survey atrial fibrillation patients to better understand patient perspective of DOAC treatment, and providers to assess knowledge, practice patterns, and beliefs surrounding anticoagulation for AF.
What is the current status of trial NCT03719144?
This trial is currently completed. The enrollment target is 581 participants. The study started on 2019-04-08. Estimated completion is 2020-03-24.
What conditions does trial NCT03719144 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
Who is sponsoring clinical trial NCT03719144?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03719144 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.